Search Within

Marie Elizabeth Will

  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Journal Article (5)
  2. Meeting Abstract (4)
Groups
  1. Department of Medicine (9)
  2. GME, Medicine (9)
  3. GSK Faculty (9)
  4. Graduate Medical Education (9)
  5. Hematology-Oncology Fellows (9)
  6. Sloan Kettering Institute Postdocs (9)

More Groups

People
  1. Sarat Chandarlapaty (7)
  2. Neal Rosen (6)
  3. Vanessa Rodrik - Outmezguine (6)
  4. Jose Baselga (5)
  5. Weiyi Toy (3)
  6. Alicia Latham (2)

More People

Years
  1. 2024 (2)
  2. 2023 (1)
  3. 2015 (2)
  4. 2014 (1)
  5. 2013 (1)
  6. 2012 (2)
Publications
  1. Cancer Cell (2)
  2. Cancer Research (2)
  3. European Journal of Cancer (2)
  4. Cancer Discovery (1)
  5. European Journal of Human Genetics (1)
  6. JNCI: Journal of the National Cancer Institute (1)
Publishers
  1. American Association for Cancer Research (3)
  2. Cell Press (2)
  3. Elsevier Inc. (2)
  4. Nature Publishing Group (1)
  5. Oxford University Press (1)

Results (9)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Long-term breast cancer response to CDK4/6 inhibition defined by TP53-mediated geroconversion
    Journal Article

    Kudo, R.; Safonov, A.; Jones, C.; Moiso, E.; Dry, J. R.; Shao, H.; Nag, S.; da Silva, E. M.; Yildirim, S. Y.; Li, Q.; more...
    Cancer Cell (2024)

    Fulltext@MSK | Save
  • Benign splenic lesions in BAP1-tumor predisposition syndrome: A case series
    Journal Article

    Miranda, J.; Dave, P.; Kemel, Y.; Sheikh, R.; Zong, G.; Calderon, L. P.; Will, M.; Liu, Y. L.; Walsh, M.; Stadler, Z. K.; more...
    European Journal of Human Genetics (2024)

    Fulltext@MSK | Save
  • Comprehensive analysis of germline drivers in endometrial cancer
    Journal Article

    Gordhandas, S.; Rios-Doria, E.; Cadoo, K. A.; Catchings, A.; Maio, A.; Kemel, Y.; Sheehan, M.; Ranganathan, M.; Green, D.; Aryamvally, A.; more...
    JNCI: Journal of the National Cancer Institute (2023)

    Fulltext@MSK | Save
  • Adaptive and acquired mechanisms of resistance to PI3K inhibitors
    Meeting Abstract

    Chandarlapaty, S.; Scaltriti, M.; Will, M.; Li, Z.; Bosch Campos, A.; Schwartz, S.; Rodrik-Outmezguine, V. ; Berger, M.; Baselga, J.; Rosen, N.
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Feedback suppression of PI3Kα signaling in PTEN-mutated tumors is relieved by selective inhibition of PI3Kβ
    Journal Article

    Schwartz, S.; Wongvipat, J.; Trigwell, C. B.; Hancox, U.; Carver, B. S.; Rodrik-Outmezguine, V. ; Will, M.; Yellen, P.; de Stanchina, E.; Baselga, J.; more...
    Cancer Cell (2015)

    Fulltext@MSK | Save
  • Rapid induction of apoptosis by PI3K inhibitors is dependent upon their transient inhibition of RAS-ERK signaling
    Journal Article

    Will, M.; Qin, A. C. R.; Toy, W.; Yao, Z.; Rodrik-Outmezguine, V. ; Schneider, C.; Huang, X.; Monian, P.; Jiang, X.; de Stanchina, E.; more...
    Cancer Discovery (2014)

    Fulltext@MSK | Save
  • Rapid induction of apoptosis by PI3K inhibitors is dependent upon their transient inhibition of RAS signaling
    Meeting Abstract

    Will, M.; Toy, W.; Yao, Z.; Poulikakos, P.; Rodrik-Outmezguine, V. ; Schneider, C.; Paul, J.; Baselga, J.; Liu, N.; Rosen, N.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • BAY80-6946 is a potent and selective PI3K inhibitor that induces apoptosis in breast cancers by blocking AKT and non-AKT PI3K effector pathways
    Meeting Abstract

    Will, M.; Toy, W.; Patel, P.; Rodrik-Outmezguine, V.; Schneider, C.; Paul, J.; Liu, N.; Rosen, N.; Chandarlapaty, S.
    European Journal of Cancer (2012)

    Fulltext@MSK | Save
  • A mechanistic logic for dual targeting of HER2 and PI3K/AKT/mTOR signaling in HER2 amplified breast cancer
    Meeting Abstract

    Chandarlapaty, S.; Rodrik-Outmezguine, V.; Scaltriti, M. M.; Sakr, R.; Will, M.; Giri, D.; Hudis, C.; Baselga, J.; King, T.; Rosen, N.
    European Journal of Cancer (2012)

    Fulltext@MSK | Save